LeMaitre Vascular, Inc. vs. Stryker Corporation
LeMaitre Vascular, Inc. (LMAT) comes out ahead, leading on 6 of 11 compared factors.
Size & Scale
| LMAT | SYK | |
|---|---|---|
| Market Cap | $1.86 billion | $130.04 billion |
| Revenue (TTM) | $262.43 million | $25.84 billion |
| Net Income (TTM) | $65.67 million | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| LMAT | SYK | |
|---|---|---|
| P/E Ratio | 28.58 | 35.13 |
| Price / Book | 4.43 | 5.42 |
| Price / Sales | 7.10 | 5.03 |
LMAT leads on 2 of 3 valuation factors.
Profitability
| LMAT | SYK | |
|---|---|---|
| Net Margin | 25.02% | 14.43% |
| Return on Equity | 15.62% | 15.55% |
LMAT leads on 2 of 2 profitability factors.
Dividend
| LMAT | SYK | |
|---|---|---|
| Dividend Yield | 1.23% | 1.04% |
| Payout Ratio | 35.09 | 36.48 |
LMAT leads on 2 of 2 dividend factors.
Risk & Sentiment
| LMAT | SYK | |
|---|---|---|
| Short Interest | 4.36% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: LMAT overview, LMAT financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
